Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

Item
http://www.wikidata.org/entity/Q40243986
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentDifferential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantationSignal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Animal models for the study of liver fibrosis: new insights from knockout mouse models.Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantationCytokines and STATs in Liver Fibrosis.Cell signals influencing hepatic fibrosisNew Approaches for Studying Alcoholic Liver DiseaseBoth MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activationCatheterization of the gallbladder: A novel mouse model of severe acute cholangitis.Xenobiotic-induced liver injury and fibrosis.A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational studyEpidermal growth factor signaling protects from cholestatic liver injury and fibrosis.Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter.Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation.
P2860

Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

Item
http://www.wikidata.org/entity/Q40243986
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Lack of glycoprotein 130/signa ...... del of sclerosing cholangitis.
@en
type
label
Lack of glycoprotein 130/signa ...... del of sclerosing cholangitis.
@en
prefLabel
Lack of glycoprotein 130/signa ...... del of sclerosing cholangitis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Lack of glycoprotein 130/signa ...... del of sclerosing cholangitis.
@en
P2093
P2860
P304
P31
P356
10.2353/AJPATH.2010.090469
P407
P433
P478
P577
P5875
P698
P921
P932